Search results
We look forward to your inquiries and will be glad to answer all your questions: Univ.-Prof. Dr. med. Pavel Strnad. Lead Consultant and Scientific Advisor of the Alpha1-Liver Network and patient advocacy group Alpha1-Deutschland e.V. pstrnad ukaachen de. Dr. med. Malin Fromme. Resident physician.
Pavel STRNAD | Cited by 12,029 | of University Hospital RWTH Aachen, Aachen | Read 404 publications | Contact Pavel STRNAD
Univ.-Prof. Dr. med. Pavel Strnad, Leitender Oberarzt in der Medizinischen Klinik III und Leiter des Alpha1-Leberzentrums an der Uniklinik RWTH Aachen, hat mit den Kollegen Professor Jeffrey Teckman…
Dec 7, 2016 · This Review describes the responses of the liver during sepsis, to highlight the mechanisms leading to liver injury during sepsis and to delineate the impaired defence against microbial infection...
- Pavel Strnad, Frank Tacke, Alexander Koch, Christian Trautwein
- 2017
Jun 25, 2022 · Pavel Strnad, Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease, Alimentary Pharmacology & Therapeutics ...
Apr 8, 2020 · Alpha1-antitrypsin (AAT) deficiency is one of the most common genetic diseases. Most persons carry two copies of the wild-type M allele of SERPINA1, which encodes AAT, and have normal circulating...
Pavel Strnad is a full professor and leading physician at the University Hospital Aachen, Germany. In 2016, he was named one of the Rising Stars of the United European Gastroenterology. He is heading a European initiative for study of alpha1-antitrypsin deficiency-associated liver disease.
